Last reviewed · How we verify
NCT03971279
Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis
trial testing Dexamethasone Ophthalmic implant in Posterior Uveitis in 16 participants. Completed in 22 November 2019.
22 November 2019
Quick facts
| Lead sponsor | Benha University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 16 |
| Start date | 1 January 2017 |
| Primary completion | 22 November 2019 |
| Estimated completion | 22 November 2019 |
| Sites | 1 location across United Arab Emirates |
Drugs / interventions tested
- Dexamethasone Ophthalmic implant — full drug profile →
Conditions studied
- Posterior Uveitis — all drugs for Posterior Uveitis →
Sponsor
Benha University
Who can join
18 and older, any sex, with Posterior Uveitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
VKH disease is a vision threatening condition.The investigators consider that ozurdex intravitreal implant is an effective line of treatment in recurrent VKH posterior uveitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03971279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone Ophthalmic implant
Trials testing the same drug.
- NCT04667507 — Pharmacokinetics of Aqueous Dexamethasone · Phase 4 · completed
Other recruiting trials for Posterior Uveitis
Currently open trials in the same condition.
- NCT05153057 — Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD) · recruiting
Other Benha University trials
Trials by the same sponsor.
- NCT07526675 — Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer · NA · not yet recruiting
- NCT07480031 — Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilatio · NA · not yet recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
- NCT07300787 — miRNA in Pediatric Gastritis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03971279 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Benha University
- Last refreshed: 26 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03971279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing